Bradmer Pharmaceuticals Inc. (TSE:GLX) Given Consensus Recommendation of “Buy” by Analysts

Shares of Bradmer Pharmaceuticals Inc. (TSE:GLX) have been given a consensus rating of “Buy” by the eight brokerages that are currently covering the stock, MarketBeat reports. Two analysts have rated the stock with a hold rating, one has given a buy rating and five have assigned a strong buy rating to the company.

A number of equities analysts have recently commented on GLX shares. Citizens Jmp raised shares of Bradmer Pharmaceuticals to a “strong-buy” rating in a report on Tuesday, December 9th. Citigroup raised shares of Bradmer Pharmaceuticals to a “hold” rating in a research report on Tuesday, February 24th. Finally, ATB Cormark Capital Markets cut shares of Bradmer Pharmaceuticals from a “strong-buy” rating to a “moderate buy” rating in a report on Thursday, February 5th.

Bradmer Pharmaceuticals Price Performance